Previous Article | Next Article ![]()
Infection and Immunity, July 1999, p. 3430-3436, Vol. 67, No. 7
Division of Microbiology,
Received 30 November 1998/Returned for modification 5 March
1999/Accepted 13 April 1999
A possible immunomodulatory role of granulocyte colony-stimulating
factor (G-CSF) was investigated in an experimental pneumococcal meningitis model in rabbits. Animals were pretreated with G-CSF (10 µg/kg subcutaneously twice a day) starting 48 h before in vivo
and ex vivo experiments, causing a five- to six-fold increase in the
peripheral leukocyte level. Meningitis was induced by intracisternal inoculation of ~4 × 105 CFU of Streptococcus
pneumoniae type 3. Neutrophil pleocytosis and interleukin-8
(IL-8) levels were significantly attenuated in G-CSF-pretreated animals
compared to untreated animals (P < 0.05).
Furthermore, G-CSF pretreatment significantly delayed alterations in
cerebrospinal fluid (CSF) tumor necrosis factor alpha and IL-1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Pretreatment with Granulocyte Colony-Stimulating Factor
Attenuates the Inflammatory Response but Not the Bacterial Load in
Cerebrospinal Fluid during Experimental Pneumococcal Meningitis
in Rabbits
levels, as well as protein and glucose levels (P < 0.05). No difference in CSF bacterial concentrations was found, whereas
the blood bacterial concentration was significantly decreased in
G-CSF-pretreated animals (P < 0.05). Ex vivo
chemotaxis of neutrophils isolated from G-CSF-pretreated animals was
significantly decreased compared to that of neutrophils from untreated
animals (P < 0.05). In conclusion, G-CSF pretreatment
attenuates meningeal inflammation and enhances systemic bacterial
killing. Further preclinical studies are required to investigate
whether this may affect the clinical course of meningitis and thus
whether G-CSF treatment may have a beneficial role in pneumococcal meningitis.
*
Corresponding author. Mailing address: Division of
Microbiology, Department of Research and Development, Statens Serum
Institut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark. Phone: 45 32688208. Fax: 45 32683887. E-mail: coa{at}ssi.dk.
Infection and Immunity, July 1999, p. 3430-3436, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»